Results 131 to 140 of about 203,661 (259)

Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer. [PDF]

open access: yesBiomedicines, 2021
Garrido MP   +5 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

open access: yesMolecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy   +10 more
wiley   +1 more source

Medicina occidental y otras alternativas: ¿es posible su complementariedad? Reflexiones conceptuales

open access: yesCadernos de Saúde Pública
El presente documento hace parte de una serie de reflexiones sobre el abordaje intercultural de los sistemas de salud y las políticas públicas que le corresponden, provocadas por el estudio de dos hospitales mixtos (interculturales) creados en áreas ...
María Beatriz Duarte Gómez
doaj  

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey. [PDF]

open access: yesBiomol Biomed
Buhovac T   +9 more
europepmc   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Complementary therapies for the management of attention deficit hyperactivity disorder in children: a scoping review. [PDF]

open access: yesRev Lat Am Enfermagem
Szychta LF   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy